Vanderbilt Ingram Cancer Center

African American woman in pink crossing her hands over her breast

Study seeks to boost breast tumor immune response

Immunotherapy, which harnesses the power of the immune system, is one of the most promising forms of cancer therapy and has been shown to work well against some types of cancer.

Sberna named VICC Strategy and Analytics director

Theresa Sberna, MPH, has been named director of Strategy and Analytics for Vanderbilt-Ingram Cancer Center (VICC). Sberna, who previously served as associate director, has been with the Cancer Center for five years.

trailer park

Study finds higher death rates in poor neighborhoods

Living in an economically disadvantaged neighborhood is likely to lead to death at an earlier age, especially among African-Americans, new research shows. The death rate is even more pronounced among disadvantaged individuals with unhealthy lifestyle habits.

VICC, Tempus launch new data initiative to help cancer patients

Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data, and Vanderbilt-Ingram Cancer Center (VICC) have announced a new collaboration to improve outcomes for cancer patients.

Funding opportunity: Vanderbilt-Incyte Research Alliance Program Grant

The Vanderbilt–Incyte Research Alliance announces a funding opportunity to support faculty in the areas of applied and translational research.

Lung screening program continues to grow

Vanderbilt University Medical Center’s (VUMC) Lung Screening Program for patients at high risk for cancer recently reached a milestone, enrolling more than 700 patients and performing more than 1,000 CT screening examinations.

1 24 25 26 27 28 55